Liver Transplant for Hepatocellular Cancer. Very Small Tumors, Very Large Tumors, and Waiting Time

Kayvan Roayaie, Sasan Roayaie

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

The role of liver transplant for treatment of early hepatocellular cancer (HCC) is no longer contested. However, its benefit relative to other therapies for patients with very early (<2cm) HCC is still a matter of debate. Twenty years after the establishment of the Milan criteria, we are beginning to realize that the number and size of tumors may not be the best metric by which to prognosticate outcomes and allocate organs. A better assessment of tumor aggressiveness is clearly needed.

Original languageEnglish (US)
Pages (from-to)603-612
Number of pages10
JournalClinics in liver disease
Volume18
Issue number3
DOIs
StatePublished - Aug 2014

Keywords

  • Drop out
  • Expansion
  • Milan criteria
  • Recurrence
  • Resection
  • UNOS stage 1

ASJC Scopus subject areas

  • Hepatology

Fingerprint

Dive into the research topics of 'Liver Transplant for Hepatocellular Cancer. Very Small Tumors, Very Large Tumors, and Waiting Time'. Together they form a unique fingerprint.

Cite this